1. Institutions of Objectivity in Clinical CancerTrials: A History and Sociology of Data Monitoring Committees in Clinical Cancer Trials Peter Keating & Alberto Cambrosio…

1. The New Era of Alzheimer’sPrevention Treatment TrialsJessica B. Langbaum, PhDPrincipal Scientist, Banner Alzheimer’s InstituteAssociate Director, Alzheimer’s Prevention…

1 Clinical Data Management Priyanka Vijayvargiya PGDCTM, Cliniminds Bhopal 2 Data & Database A collection of factual information derived from measurement or research…

1. CNI minimization by Everolimus Evolving strategies at a single centre Decenzio BONUCCHI, MDNephrology, Dialysis and Renal Transplantation Policlinico University Hospital,…

1. NON-INTERVENTIONAL (NI) DRUG STUDY PROTOCOL STUDY OF THE UTILIZATION PATTERN OF APIXABAN IN THE NETHERLANDS 2.  Ibrahim Y. Mahamoud  Helene Saban  Ravi Kasula…

1. Newest Approach toBreast Cancer Kevin R. Fox, MDMacDonald Professor of Medicine Abramson Cancer Center University of Pennsylvania 2. To follow:• Early stage breast cancer–…

1. Medico-Legal Issues andBreech BirthSchool of Women’s & Children’s Health 2. Professor Alec WelshMBBS MSc PhD FRCOG(MFM) FRANZCOG DDU CMFMProfessor in Maternal-Fetal…

Slide 1New Strategies on Horizon Tony Mok MD Dept of Clinical Oncology The Chinse University of Hong Kong Slide 2 TKI is forever Addressing the difference Novel Target Slide…

Slide 1Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management Slide 2 Objectives Recognize Adverse Events and serious adverse events…

1. New Designs for Phase III Clinical Trials Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute http://brb.nci.nih.gov 2. BRB Website http://brb.nci.nih.gov…